Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Status: Publicly traded
Direct answer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. is publicly traded on HKSE under the ticker 6990.HK.
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, metabolism, and other therapeutic areas in the People’s Republic of China and internationally. The company’s product pipeline includes Sac-TMT, a novel TROP2 ADC positioned as a monotherapy and part of combination...
Can you invest in Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.?
Yes. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. trades publicly on HKSE as 6990.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Detailed equity research is provided by MarketSnap.